SCHEMBL14875461

SCHEMBL14875461

O=C(O)NC1CCC(c2c[nH]c3cnccc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 8/20 0.47
HSD11B1 P28845 1/20 0.46
IGF1R P08069 1/20 0.44
CDK2 P24941 1/20 0.44
DYRK1B Q9Y463 1/20 0.44
CYP46A1 Q9Y6A2 2/20 0.41
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.38
BRD4 O60885 1/20 0.38
POLB P06746 1/20 0.38
CREBBP Q92793 1/20 0.38
GSK3B P49841 2/20 0.38
DYRK1A Q13627 2/20 0.38
HTR1A P08908 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1F P30939 1/20 0.38
NFATC1 O95644 1/20 0.38
PDPK1 O15530 1/20 0.36
TGFBR1 P36897 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12326969 0.83 JAK1 (0.48) CCR2HSD11B1IGF1RCDK2DYRK1B
SCHEMBL28328563 0.82 SLC6A4 (0.45) CCR2HSD11B1IGF1RCDK2DYRK1B
SCHEMBL2468384 0.79 HSD11B1 (0.60) CCR2HSD11B1CYP46A1ALDH1A1KDM4E
SCHEMBL12315639 0.77 HSD11B1 (0.48) HSD11B1GSK3BDYRK1ANFATC1PDPK1
SCHEMBL13021101 0.76 HTR2C (0.62) CCR2HSD11B1GSK3BDYRK1AHTR1F
SCHEMBL28328609 0.75 DRD3 (0.55) HTR1A
SCHEMBL16801608 0.75 KDM4E (0.69) CCR2HSD11B1IGF1RCDK2DYRK1B
SCHEMBL2467357 0.74 HSD11B1 (0.44) CCR2HSD11B1IGF1RCDK2DYRK1B
SCHEMBL22049740 0.74 TRPV1 (0.53) ALDH1A1L3MBTL1
SCHEMBL28328565 0.73 HSD11B1 (0.59) CCR2HSD11B1ALDH1A1KDM4EBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227967-B2 Inhibitor compounds of semicarbazide-sensitive amine oxidases PROXIMAGEN LIMITED (GB) 2016-01-05 US disclosed
EP-2927233-A1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE Proximagen Limited (GB) 2015-10-07 EP disclosed
EP-2547677-B1 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE PROXIMAGEN LTD (GB) 2015-05-06 EP disclosed
US-20130102587-A1 New Enzyme Inhibitor Compounds PROXIMAGEN LIMITED (GB) 2013-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102587-A1 New Enzyme Inhibitor Compounds SERPINB1, SSB, NFKBIA CCR2 3874/4885HSD11B1 835/4885IGF1R 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.